CoronaryAtlas logo
CoronaryAtlas
Methionine sulfoxide
Pathway / Plaque inflammation

Methionine sulfoxide

metabolite

Methionine sulfoxide is an oxidized amino acid product reflecting oxidative stress and plaque inflammation in acute myocardial infarction.

Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleOxidized amino acid; oxidative stress and inflammation marker.
Also acts inSystemic / off-pathway
Druggability
Not assessed (no mapped human gene target).

Type I vs Type II discrimination

ScoresLow-confidence (proxy)
R — rupture / Type-I
33
C — confounder / Type-II
50
A — assay feasibility
42
E — evidence strength
20
T1DI (composite)
3
Specificity differential (R−C)-16.9
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research

Literature evidence(1)